Alexander L. Johnson - Feb 1, 2023 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Chief Business Officer
Signature
/s/ Reginald Seeto, as attorney-in-fact for Alexander L. Johnson
Stock symbol
CDNA
Transactions as of
Feb 1, 2023
Transactions value $
-$59,203
Form type
4
Date filed
2/3/2023, 08:46 PM
Previous filing
Jan 31, 2023
Next filing
Jun 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Award $0 +85.1K +75.75% $0.00 197K Feb 1, 2023 Direct F1
transaction CDNA Common Stock Award $0 +3.2K +1.62% $0.00 201K Feb 1, 2023 Direct F2
transaction CDNA Common Stock Tax liability -$9.68K -618 -0.31% $15.66 200K Feb 1, 2023 Direct F3
transaction CDNA Common Stock Tax liability -$35.7K -2.03K -1.01% $17.61 198K Feb 2, 2023 Direct F4
transaction CDNA Common Stock Tax liability -$6.9K -417 -0.21% $16.54 198K Feb 3, 2023 Direct F4
transaction CDNA Common Stock Tax liability -$6.9K -417 -0.21% $16.54 197K Feb 3, 2023 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Stock Option (right to buy) Award $0 +44.1K $0.00 44.1K Feb 1, 2023 Common Stock 44.1K $15.66 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 1, 2024 and 1/4th of which shall vest on each anniversary thereafter.
F2 The reported securities were subject to a performance restricted stock unit award that was initially granted on February 3, 2021 for a two-year performance period over calendar years 2021 and 2022, which performance was assessed and finalized effective February 1, 2023. 50.00% of the reported securities vested on February 1, 2023 and 50% of the reported securities will vest on December 31, 2023, subject to the Reporting Person's continued service with the Issuer.
F3 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of performance restricted stock units.
F4 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
F5 1/4th of the shares subject to the option shall vest on February 1, 2024 and 1/48th of the shares subject to the option shall vest monthly thereafter.